| Epidemiology of non-alcoholic and alcoholic fatty liver diseases S Mitra, A De, A Chowdhury Translational gastroenterology and hepatology 5, 2020 | 449 | 2020 |
| Natural history of simple steatosis or nonalcoholic fatty liver A De, A Duseja Journal of Clinical and Experimental Hepatology 10 (3), 255-262, 2020 | 56 | 2020 |
| Outcomes after multiple courses of granulocyte colony‐stimulating factor and growth hormone in decompensated cirrhosis: a randomized trial N Verma, A Kaur, R Sharma, A Bhalla, N Sharma, A De, V Singh Hepatology 68 (4), 1559-1573, 2018 | 55 | 2018 |
| Low-dose sofosbuvir is safe and effective in treating chronic hepatitis C in patients with severe renal impairment or end-stage renal disease S Taneja, A Duseja, A De, M Mehta, R Ramachandran, V Kumar, ... Digestive diseases and sciences 63, 1334-1340, 2018 | 49 | 2018 |
| Nonalcoholic fatty liver disease: Indian perspective A De, A Duseja Clinical Liver Disease 18 (3), 158-163, 2021 | 39 | 2021 |
| NAFLD vs. MAFLD–It is not the name but the disease that decides the outcome in fatty liver A De, N Ahmad, M Mehta, P Singh, A Duseja Journal of Hepatology 76 (2), 475-477, 2022 | 30 | 2022 |
| Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD A De, N Bhagat, M Mehta, S Taneja, A Duseja Journal of hepatology 80 (2), e61-e62, 2024 | 28 | 2024 |
| Multiple cycles of granulocyte colony-stimulating factor increase survival times of patients with decompensated cirrhosis in a randomized trial A De, S Kumari, A Singh, A Kaur, R Sharma, A Bhalla, N Sharma, N Kalra, ... Clinical Gastroenterology and Hepatology 19 (2), 375-383. e5, 2021 | 28 | 2021 |
| Sofosbuvir with NS 5A inhibitors in hepatitis C virus infection with severe renal insufficiency A Singh, S Kumari, P Kumar, A De, V Singh Journal of Viral Hepatitis 25 (12), 1501-1506, 2018 | 27 | 2018 |
| A comparison of different frailty scores and impact of frailty on outcome in patients with cirrhosis S Singh, S Taneja, P Tandon, A Bansal, U Gorsi, A Roy, A De, N Verma, ... Journal of Clinical and Experimental Hepatology 12 (2), 398-408, 2022 | 23 | 2022 |
| guidance paper on nomenclature, diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD) A Duseja, SP Singh, A De, K Madan, PN Rao, A Shukla, ... J Clin Exp Hepatol 13 (2), 273-302, 2023 | 22 | 2023 |
| Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end‐stage renal disease on maintenance haemodialysis S Taneja, A Duseja, M Mehta, A De, N Verma, M Premkumar, RK Dhiman, ... Liver International 41 (4), 705-709, 2021 | 22 | 2021 |
| Impact of metabolic risk factors on the severity and outcome of patients with alcohol‐associated acute‐on‐chronic liver failure A Duseja, A De, S Taneja, AK Choudhury, H Devarbhavi, J Hu, SS Hamid, ... Liver International 41 (1), 150-157, 2021 | 19 | 2021 |
| Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients S Taneja, A Duseja, A De, V Kumar, R Ramachandran, A Sharma, ... Nephrology 23 (9), 876-882, 2018 | 19 | 2018 |
| Indian national association for study of the liver (INASL) guidance paper on nomenclature, diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD) A Duseja, SP Singh, A De, K Madan, PN Rao, A Shukla, G Choudhuri, ... Journal of clinical and experimental hepatology 13 (2), 273-302, 2023 | 15 | 2023 |
| Duodenal tuberculosis: dig deep to diagnose A De, S Lamoria, S Dhawan, S Agarwal, V Sharma Tropical Doctor 46 (3), 172-174, 2016 | 15 | 2016 |
| Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena A Bashir, A Duseja, A De, M Mehta, P Tiwari Liver Research 6 (2), 72-83, 2022 | 12 | 2022 |
| Assessment of sarcopenia using muscle ultrasound in patients with cirrhosis and sarcopenic obesity (AMUSE STUDY) S Dhariwal, A Roy, S Taneja, A Bansal, U Gorsi, S Singh, A De, N Verma, ... Journal of Clinical Gastroenterology 57 (8), 841-847, 2023 | 10 | 2023 |
| Asia–Pacific association for study of liver guidelines on management of ascites in liver disease V Singh, A De, R Mehtani, P Angeli, R Maiwall, S Satapathy, AK Singal, ... Hepatology International 17 (4), 792-826, 2023 | 10 | 2023 |
| Hand-grip strength as a screening tool for sarcopenia in males with decompensated cirrhosis A De, S Kumari, A Kaur, A Singh, N Kalra, V Singh Indian Journal of Gastroenterology 41 (3), 284-291, 2022 | 10 | 2022 |
Nipun VermaPostgraduate Institute of Medical Education and Research,ChandigarhVerified email at pgimer.edu.in
